Proliferation PET/CT Imaging of Salivary Gland Tumor

Salivary gland tumors are rare neoplasms which vary in terms of origin and malignant potential. 2-[18F]-fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET) has limited ability to differentiate between different types of salivary gland tumors because both Warthin’s tumors and pleomorphi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Ryogo Minamimoto
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/fad3d8eca6e346fe9975a3a895069a53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fad3d8eca6e346fe9975a3a895069a53
record_format dspace
spelling oai:doaj.org-article:fad3d8eca6e346fe9975a3a895069a532021-11-25T17:21:18ZProliferation PET/CT Imaging of Salivary Gland Tumor10.3390/diagnostics111120652075-4418https://doaj.org/article/fad3d8eca6e346fe9975a3a895069a532021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2065https://doaj.org/toc/2075-4418Salivary gland tumors are rare neoplasms which vary in terms of origin and malignant potential. 2-[18F]-fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET) has limited ability to differentiate between different types of salivary gland tumors because both Warthin’s tumors and pleomorphic adenomas usually show increased FDG uptake, with no statistically significant difference in standardized uptake value (SUV) compared with malignant salivary gland tumors. Here, we discuss 4′-[methyl-11C]-thiothymidine (4DST) PET, which provides cell proliferation imaging capable of demonstrating intense uptake in parotid carcinoma and Warthin’s tumor, but no uptake in parotid pleomorphic adenoma. This is the first report of the potential of proliferation PET/ computed tomography (CT) imaging for characterizing salivary gland tumors based on the molecular pathogenesis of the tumor.Ryogo MinamimotoMDPI AGarticle4DST PET/CTcell proliferation imagingFDG PET/CTsalivary gland tumorpleomorphic adenomaWarthin’s tumorMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2065, p 2065 (2021)
institution DOAJ
collection DOAJ
language EN
topic 4DST PET/CT
cell proliferation imaging
FDG PET/CT
salivary gland tumor
pleomorphic adenoma
Warthin’s tumor
Medicine (General)
R5-920
spellingShingle 4DST PET/CT
cell proliferation imaging
FDG PET/CT
salivary gland tumor
pleomorphic adenoma
Warthin’s tumor
Medicine (General)
R5-920
Ryogo Minamimoto
Proliferation PET/CT Imaging of Salivary Gland Tumor
description Salivary gland tumors are rare neoplasms which vary in terms of origin and malignant potential. 2-[18F]-fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET) has limited ability to differentiate between different types of salivary gland tumors because both Warthin’s tumors and pleomorphic adenomas usually show increased FDG uptake, with no statistically significant difference in standardized uptake value (SUV) compared with malignant salivary gland tumors. Here, we discuss 4′-[methyl-11C]-thiothymidine (4DST) PET, which provides cell proliferation imaging capable of demonstrating intense uptake in parotid carcinoma and Warthin’s tumor, but no uptake in parotid pleomorphic adenoma. This is the first report of the potential of proliferation PET/ computed tomography (CT) imaging for characterizing salivary gland tumors based on the molecular pathogenesis of the tumor.
format article
author Ryogo Minamimoto
author_facet Ryogo Minamimoto
author_sort Ryogo Minamimoto
title Proliferation PET/CT Imaging of Salivary Gland Tumor
title_short Proliferation PET/CT Imaging of Salivary Gland Tumor
title_full Proliferation PET/CT Imaging of Salivary Gland Tumor
title_fullStr Proliferation PET/CT Imaging of Salivary Gland Tumor
title_full_unstemmed Proliferation PET/CT Imaging of Salivary Gland Tumor
title_sort proliferation pet/ct imaging of salivary gland tumor
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/fad3d8eca6e346fe9975a3a895069a53
work_keys_str_mv AT ryogominamimoto proliferationpetctimagingofsalivaryglandtumor
_version_ 1718412507322777600